{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:48:21Z","timestamp":1791316101921,"version":"4.3.1"},"reference-count":138,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.nano.2015.03.008","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T03:16:12Z","timestamp":1428290172000},"page":"1481-1498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment\/therapy"],"prefix":"10.1016","volume":"11","author":[{"given":"Daniel","family":"Sep\u00falveda-Crespo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"De La Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa. \u00c1ngeles","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2015.03.008_bb0005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35073673","article-title":"HIV chemotherapy","volume":"410","author":"Richman","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nano.2015.03.008_bb0010","first-page":"595762","article-title":"Cost-effectiveness of antiretroviral therapy for multidrug-resistant HIV: past, present, and future","volume":"2012","author":"Harris","year":"2012","journal-title":"AIDS Res Treat"},{"key":"10.1016\/j.nano.2015.03.008_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1475-9276-13-18","article-title":"Socioeconomic inequalities in HIV\/AIDS prevalence in sub-Saharan African countries: evidence from the Demographic Health Surveys","volume":"13","author":"Hajizadeh","year":"2014","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.nano.2015.03.008_bb0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","article-title":"HIV infection: epidemiology, pathogenesis, treatment, and prevention","volume":"384","author":"Maartens","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2015.03.008_bb0025","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/aji.12244","article-title":"Interactions between HIV-1 and mucosal cells in the female reproductive tract","volume":"71","author":"Shen","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.nano.2015.03.008_bb0030","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1371\/journal.pmed.0030379","article-title":"Was the \u201cABC\u201d approach (abstinence, being faithful, using condoms) responsible for Uganda's decline in HIV?","volume":"3","author":"Murphy","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.nano.2015.03.008_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/bmj.324.7331.183","article-title":"How men's power over women fuels the HIV epidemic","volume":"324","author":"Gupta","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.nano.2015.03.008_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12703\/P6-43","article-title":"Developments in HIV-1 immunotherapy and therapeutic vaccination","volume":"6","author":"Smith","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.nano.2015.03.008_bb0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jcph.292","article-title":"Topical microbicides and HIV prevention in the female genital tract","volume":"54","author":"Cottrell","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.nano.2015.03.008_bb0050","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1371\/journal.pone.0001312","article-title":"SAVVY (C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana","volume":"2","author":"Peterson","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.03.008_bb0055","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","article-title":"Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial","volume":"360","author":"Van Damme","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2015.03.008_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2011.03.176","article-title":"The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1","volume":"90","author":"Pirrone","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nano.2015.03.008_bb0065","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: a review","volume":"190C","author":"Ensign","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.008_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/21691401.2014.883400","article-title":"Nanotechnology: a magic bullet for HIV AIDS treatment","volume":"43","author":"Kumar","year":"2014","journal-title":"Artif Cells Nanomedicine Biotechnol"},{"key":"10.1016\/j.nano.2015.03.008_bb0075","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1211\/jpp.61.08.0002","article-title":"Dendrimers as therapeutic agents: a systematic review","volume":"61","author":"Gajbhiye","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2015.03.008_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2014.10.014","article-title":"Nanotech-derived topical microbicides for HIV prevention: the road to clinical development","volume":"113C","author":"Sanchez-Rodriguez","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.nano.2015.03.008_bb0085","doi-asserted-by":"crossref","first-page":"e12309","DOI":"10.1371\/journal.pone.0012309","article-title":"Structure activity relationship of dendrimer microbicides with dual action antiviral activity","volume":"5","author":"Tyssen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.03.008_bb0090","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1517\/17425247.2014.888055","article-title":"Vaginal microbicides and their delivery platforms","volume":"11","author":"D'Cruz","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2015.03.008_bb0095","doi-asserted-by":"crossref","first-page":"e94547","DOI":"10.1371\/journal.pone.0094547","article-title":"A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV","volume":"9","author":"Kizima","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.03.008_bb0100","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(08)60886-7","article-title":"Behavioural strategies to reduce HIV transmission: how to make them work better","volume":"372","author":"Coates","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2015.03.008_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.nano.2015.03.008_bb0110","doi-asserted-by":"crossref","first-page":"e61416","DOI":"10.1371\/journal.pone.0061416","article-title":"Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis","volume":"8","author":"Chaowanachan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.03.008_bb0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/QAD.0000000000000131","article-title":"Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings","volume":"28","author":"Cooper","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.nano.2015.03.008_bb0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.virol.2011.07.004","article-title":"Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C","volume":"417","author":"Ferir","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.nano.2015.03.008_bb0125","first-page":"3591","article-title":"Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides","volume":"9","author":"Vacas-Cordoba","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2015.03.008_bb0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.nano.2013.10.002","article-title":"Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide","volume":"10","author":"Sepulveda-Crespo","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2015.03.008_bb0135","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1097\/QAD.0b013e328361fa4a","article-title":"Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro","volume":"27","author":"Cordoba","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.nano.2015.03.008_bb0140","doi-asserted-by":"crossref","DOI":"10.2217\/nnm.14.79","article-title":"Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission","volume":"10","author":"Sepulveda-Crespo","year":"2015","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2015.03.008_bb0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nano.2015.03.008_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.nano.2015.03.008_bb0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.16.4.569-596.2003","article-title":"Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections","volume":"16","author":"De Clercq","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.nano.2015.03.008_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3851\/IMP2311","article-title":"Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial","volume":"18","author":"Sokal","year":"2013","journal-title":"Antivir Ther"},{"key":"10.1016\/j.nano.2015.03.008_bb0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/QCO.0b013e32834ef5ef","article-title":"Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence","volume":"25","author":"Celum","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.nano.2015.03.008_bb0170","author":"FACTS"},{"key":"10.1016\/j.nano.2015.03.008_bb0175","author":"Clinical Trials"},{"key":"10.1016\/j.nano.2015.03.008_bb0180","author":"MTN"},{"key":"10.1016\/j.nano.2015.03.008_bb0185","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1089\/aid.2012.0262","article-title":"RMP-02\/MTN-006: a phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate","volume":"28","author":"Anton","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.nano.2015.03.008_bb0190","doi-asserted-by":"crossref","first-page":"e6014","DOI":"10.1371\/journal.pone.0060147","article-title":"A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007)","volume":"8","author":"McGowan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.03.008_bb0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/17425247.2013.860132","article-title":"The development of rectal microbicides for HIV prevention","volume":"11","author":"McGowan","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2015.03.008_bb0200","author":"MTN"},{"key":"10.1016\/j.nano.2015.03.008_bb0205","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2015.03.008_bb0210","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2147\/IJWH.S36282","article-title":"Vaginal rings for delivery of HIV microbicides","volume":"4","author":"Malcolm","year":"2012","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.nano.2015.03.008_bb0215","author":"MTN"},{"key":"10.1016\/j.nano.2015.03.008_bb0220","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.progpolymsci.2005.01.007","article-title":"Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry","volume":"30","author":"Tomalia","year":"2005","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.nano.2015.03.008_bb0225","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1039\/B917370F","article-title":"Dendrons\/dendrimers: quantized, nano-element like building blocks for soft-soft and soft-hard nano-compound synthesis","volume":"6","author":"Tomalia","year":"2010","journal-title":"Soft Matter"},{"key":"10.1016\/j.nano.2015.03.008_bb0230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1295\/polymj.17.117","article-title":"A new class of polymers: starburst-dendritic macromolecules","volume":"17","author":"Tomalia","year":"1985","journal-title":"Polym J"},{"key":"10.1016\/j.nano.2015.03.008_bb0235","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2217\/nnm.11.67","article-title":"Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties","volume":"6","author":"Kaminskas","year":"2011","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2015.03.008_bb0240","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.nano.2015.03.008_bb0245","first-page":"70","article-title":"Dendrimer: a novel drug delivery system","volume":"1","author":"Ina","year":"2011","journal-title":"J Drug Deliv Ther"},{"key":"10.1016\/j.nano.2015.03.008_bb0250","first-page":"142","article-title":"Dendrimers and their applications as novel drug delivery carriers","volume":"3","author":"Tripathy","year":"2013","journal-title":"J Appl Pharm Sci"},{"key":"10.1016\/j.nano.2015.03.008_bb0255","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/joim.12280","article-title":"Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications","volume":"276","author":"Kannan","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.nano.2015.03.008_bb0260","doi-asserted-by":"crossref","first-page":"837651","DOI":"10.1155\/2014\/837651","article-title":"Modeling dendrimers charge interaction in solution: relevance in biosystems","volume":"2014","author":"Lombardo","year":"2014","journal-title":"Biochem Res Int"},{"key":"10.1016\/j.nano.2015.03.008_bb0265","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1039\/B901839P","article-title":"Biomedical applications of dendrimers: a tutorial","volume":"40","author":"Mintzer","year":"2011","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2015.03.008_bb0270","first-page":"39","article-title":"Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic organic chemistry","volume":"37","author":"Tomalia","year":"2004","journal-title":"Aldrichimica Acta"},{"key":"10.1016\/j.nano.2015.03.008_bb0275","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.addr.2005.09.018","article-title":"Dendrimers in biomedical applications\u2014reflections on the field","volume":"57","author":"Svenson","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.03.008_bb0280","doi-asserted-by":"crossref","first-page":"12880","DOI":"10.1002\/chem.201200231","article-title":"2,2\u2032:3\u2032,2\u2033-Terthiophene-based all-thiophene dendrons and dendrimers: synthesis, structural characterization, and properties","volume":"18","author":"Ma","year":"2012","journal-title":"Chemistry"},{"key":"10.1016\/j.nano.2015.03.008_bb0285","first-page":"77","article-title":"Spectroscopic characterization of dendrimers","volume":"4","author":"Gautam","year":"2012","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.nano.2015.03.008_bb0290","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1021\/ma025752n","article-title":"Structure and dimensions of PAMAM\/PEG dendrimer\u2013star polymers","volume":"36","author":"Hedden","year":"2003","journal-title":"Macromolecules"},{"key":"10.1016\/j.nano.2015.03.008_bb0295","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/polym4010600","article-title":"Characterizations of polyamidoamine dendrimers with scattering techniques","volume":"4","author":"Wang","year":"2012","journal-title":"Polymers"},{"key":"10.1016\/j.nano.2015.03.008_bb0300","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1021\/la000035c","article-title":"Visualization and characterization of poly(amidoamine) dendrimers by atomic force microscopy","volume":"16","author":"Li","year":"2000","journal-title":"Langmuir"},{"key":"10.1016\/j.nano.2015.03.008_bb0305","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.1021\/ja00177a027","article-title":"Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules","volume":"112","author":"Hawker","year":"1990","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2015.03.008_bb0310","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0975-7406.130965","article-title":"Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues","volume":"6","author":"Madaan","year":"2014","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.nano.2015.03.008_bb0315","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1039\/c3cc44067b","article-title":"A durable template for carbosilane dendrimer synthesis","volume":"49","author":"Son","year":"2013","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.nano.2015.03.008_bb0320","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1016\/j.tet.2010.09.063","article-title":"Synthesis of carbosilane dendrons and dendrimers derived from 1,3,5-trihydroxybenzene","volume":"66","author":"S\u00e1nchez-Nieves","year":"2010","journal-title":"Tetrahedron"},{"key":"10.1016\/j.nano.2015.03.008_bb0325","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1039\/c4ob00162a","article-title":"Synthesis of new anionic carbosilane dendrimers via thiol-ene chemistry and their antiviral behaviour","volume":"12","author":"Galan","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0330","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.addr.2005.09.017","article-title":"Dendrimers in gene delivery","volume":"57","author":"Dufes","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.03.008_bb0335","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1359-6446(01)01757-3","article-title":"Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications","volume":"6","author":"Esfand","year":"2001","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nano.2015.03.008_bb0340","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jasms.2008.06.016","article-title":"Electron capture dissociation, electron detachment dissociation, and collision-induced dissociation of polyamidoamine (PAMAM) dendrimer ions with amino, amidoethanol, and sodium carboxylate surface groups","volume":"19","author":"Kaczorowska","year":"2008","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.nano.2015.03.008_bb0345","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1021\/cr970069y","article-title":"About dendrimers: structure, physical properties, and applications","volume":"99","author":"Bosman","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2015.03.008_bb0350","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1051\/jphyslet:01983004409035100","article-title":"Statistics of \u201cstarburst\u201d polymers","volume":"44","author":"de Gennes","year":"1983","journal-title":"J Phys Lett"},{"key":"10.1016\/j.nano.2015.03.008_bb0355","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","article-title":"Dendrimer biocompatibility and toxicity","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.03.008_bb0360","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3109\/17435390.2011.604442","article-title":"Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles","volume":"6","author":"Greish","year":"2012","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.nano.2015.03.008_bb0365","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bioelechem.2003.09.023","article-title":"Influence of PAMAM dendrimers on human red blood cells","volume":"63","author":"Domanski","year":"2004","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.nano.2015.03.008_bb0370","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0378-5173(02)00623-3","article-title":"The influence of surface modification on the cytotoxicity of PAMAM dendrimers","volume":"252","author":"Jevprasesphant","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2015.03.008_bb0375","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jconrel.2012.04.050","article-title":"Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile","volume":"161","author":"Chonco","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.008_bb0380","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/QAD.0b013e32835f2b7a","article-title":"Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission","volume":"27","author":"Vacas Cordoba","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.nano.2015.03.008_bb0385","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-59745-393-6_4","article-title":"The C type lectins DC-SIGN and L-SIGN: receptors for viral glycoproteins","volume":"379","author":"Lozach","year":"2007","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nano.2015.03.008_bb0390","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/bc034008k","article-title":"Glycodendritic structures based on Boltorn hyperbranched polymers and their interactions with Lens culinaris lectin","volume":"14","author":"Arce","year":"2003","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0395","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.febslet.2006.03.061","article-title":"Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding","volume":"580","author":"Tabarani","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nano.2015.03.008_bb0400","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/cb900216e","article-title":"Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation","volume":"5","author":"Sattin","year":"2010","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.nano.2015.03.008_bb0405","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/QAD.0b013e32834e1567","article-title":"A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models","volume":"26","author":"Berzi","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.nano.2015.03.008_bb0410","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.biomaterials.2014.01.014","article-title":"A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and dengue virus","volume":"35","author":"Varga","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.03.008_bb0415","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/jac\/dkh399","article-title":"Glycodendritic structures: promising new antiviral drugs","volume":"54","author":"Rojo","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2015.03.008_bb0420","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1128\/JVI.69.12.7383-7390.1995","article-title":"Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide\/3' sulfo-galactosyl ceramide-positive cell line","volume":"69","author":"Harouse","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2015.03.008_bb0425","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/bc034156a","article-title":"Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120","volume":"15","author":"Kensinger","year":"2004","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0430","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1128\/AAC.48.5.1614-1623.2004","article-title":"Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection","volume":"48","author":"Kensinger","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2015.03.008_bb0435","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/ejoc.201000132","article-title":"Synthesis of hyperbranched \u03b2-galceramide-containing dendritic polymers that bind HIV-1 rgp120","volume":"2010","author":"Morales-Serna","year":"2010","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0440","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/cbic.200500203","article-title":"Dendritic catanionic assemblies: in vitro anti-HIV activity of phosphorus-containing dendrimers bearing galbeta1cer analogues","volume":"6","author":"Blanzat","year":"2005","journal-title":"Chembiochem"},{"key":"10.1016\/j.nano.2015.03.008_bb0445","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bmc.2009.10.058","article-title":"Multivalent catanionic GalCer analogs derived from first generation dendrimeric phosphonic acids","volume":"18","author":"Perez-Anes","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0450","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1039\/b204287h","article-title":"Phosphorus-containing dendrimers bearing galactosylceramide analogs: self-assembly properties","author":"Blanzat","year":"2002","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.nano.2015.03.008_bb0455","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1039\/b908352a","article-title":"Phosphonate terminated PPH dendrimers: influence of pendant alkyl chains on the in vitro anti-HIV-1 properties","volume":"7","author":"Perez-Anes","year":"2009","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0460","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.carbpol.2012.06.044","article-title":"Synthesis of a new amphiphilic glycodendrimer with antiviral functionality","volume":"90","author":"Han","year":"2012","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2015.03.008_bb0465","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.carbpol.2010.01.031","article-title":"Sulfated oligosaccharide cluster with polylysine core scaffold as a new anti-HIV dendrimer","volume":"80","author":"Han","year":"2010","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2015.03.008_bb0470","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/cr000418f","article-title":"The cluster glycoside effect","volume":"102","author":"Lundquist","year":"2002","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2015.03.008_bb0475","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.carbpol.2006.07.004","article-title":"Synthesis of new spherical and hemispherical oligosaccharides with polylysine core scaffold","volume":"68","author":"Han","year":"2007","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2015.03.008_bb0480","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.semcdb.2004.03.007","article-title":"The cell biology of glycosphingolipids","volume":"15","author":"Degroote","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.nano.2015.03.008_bb0485","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2010.09.004","article-title":"Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1","volume":"408","author":"Rosa Borges","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.nano.2015.03.008_bb0490","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1021\/bc200331v","article-title":"Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds","volume":"22","author":"Clayton","year":"2011","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0495","first-page":"1","article-title":"HIV-1 entry and its inhibition","volume":"281","author":"Pierson","year":"2003","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.nano.2015.03.008_bb0500","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-containing HIV-1 gp120 core","volume":"310","author":"Huang","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nano.2015.03.008_bb0505","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0161-5890(93)90124-T","article-title":"CD4-derived peptide and sulfated polysaccharides have similar mechanisms of anti-HIV activity based on electrostatic interactions with positively charged gp120 fragments","volume":"30","author":"Meshcheryakova","year":"1993","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nano.2015.03.008_bb0510","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1126\/science.280.5371.1949","article-title":"A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding","volume":"280","author":"Rizzuto","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.nano.2015.03.008_bb0515","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1124\/mol.58.5.1100","article-title":"Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase\/integrase) in the virus replicative cycle","volume":"58","author":"Witvrouw","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nano.2015.03.008_bb0520","doi-asserted-by":"crossref","first-page":"024905","DOI":"10.1063\/1.4812801","article-title":"Simulations reveal that the HIV-1 gp120-CD4 complex dissociates via complex pathways and is a potential target of the polyamidoamine (PAMAM) dendrimer","volume":"139","author":"Nandy","year":"2013","journal-title":"J Chem Phys"},{"key":"10.1016\/j.nano.2015.03.008_bb0525","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/mp050023q","article-title":"Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention","volume":"2","author":"McCarthy","year":"2005","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2015.03.008_bb0530","first-page":"561","article-title":"VivaGel (SPL7013 Gel): a candidate dendrimer\u2013microbicide for the prevention of HIV and HSV infection","volume":"2","author":"Rupp","year":"2007","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2015.03.008_bb0535","doi-asserted-by":"crossref","first-page":"e24095","DOI":"10.1371\/journal.pone.0024095","article-title":"SPL7013 Gel (VivaGel(R)) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans","volume":"6","author":"Price","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.03.008_bb0540","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.03.186","article-title":"Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1","volume":"90","author":"Telwatte","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nano.2015.03.008_bb0545","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/QAI.0b013e31823f2aeb","article-title":"Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety","volume":"59","author":"Moscicki","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nano.2015.03.008_bb0550","doi-asserted-by":"crossref","first-page":"12733","DOI":"10.1039\/c2dt31099f","article-title":"Synthesis, structure and molecular modelling of anionic carbosilane dendrimers","volume":"41","author":"Rasines","year":"2012","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nano.2015.03.008_bb0555","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/pola.27090","article-title":"Synthesis of anionic carbosilane dendrimers via \u201cclick chemistry\u201d and their antiviral properties against HIV","volume":"52","author":"Arn\u00e1iz","year":"2014","journal-title":"J Polym Sci A1"},{"key":"10.1016\/j.nano.2015.03.008_bb0560","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.2174\/0929867311209024984","article-title":"Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization","volume":"19","author":"Galan","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0565","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1111\/j.1742-4658.2009.07314.x","article-title":"The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly","volume":"276","author":"Neira","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.nano.2015.03.008_bb0570","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1021\/bm100432x","article-title":"Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV-1","volume":"11","author":"Domenech","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2015.03.008_bb0575","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature05817","article-title":"Heparan sulphate proteoglycans fine-tune mammalian physiology","volume":"446","author":"Bishop","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.nano.2015.03.008_bb0580","doi-asserted-by":"crossref","first-page":"e76482","DOI":"10.1371\/journal.pone.0076482","article-title":"Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures","volume":"8","author":"Bon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.03.008_bb0585","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1021\/jm100093p","article-title":"\"Viologen\" dendrimers as antiviral agents: the effect of charge number and distance","volume":"53","author":"Asaftei","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0590","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1021\/jm301337y","article-title":"HIV-1 X4 activities of polycationic \u201cviologen\u201d based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationship","volume":"55","author":"Asaftei","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0595","first-page":"10","article-title":"PEG conjugated PAMAM dendrimers with a anti-HIV drug stavudine for prolong release","volume":"4","author":"Kumar","year":"2013","journal-title":"Res Biotechnol"},{"key":"10.1016\/j.nano.2015.03.008_bb0600","first-page":"08","article-title":"Prolonged drug delivery system of PEGylated PAMAM dendrimers with a anti-HIV drug","volume":"3","author":"Kumar","year":"2013","journal-title":"Res Pharm"},{"key":"10.1016\/j.nano.2015.03.008_bb0605","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2008.04.002","article-title":"Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro","volume":"34","author":"Dutta","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2015.03.008_bb0610","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bbagen.2006.12.007","article-title":"Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer","volume":"1770","author":"Dutta","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2015.03.008_bb0615","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejps.2012.12.027","article-title":"Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers","volume":"48","author":"Gajbhiye","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2015.03.008_bb0620","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/2230-973X.127735","article-title":"Polyethylene glycolated PAMAM dendrimers-Efavirenz conjugates","volume":"4","author":"Pyreddy","year":"2014","journal-title":"Int J Pharm Invest"},{"key":"10.1016\/j.nano.2015.03.008_bb0625","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.4049\/jimmunol.1002846","article-title":"Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV","volume":"185","author":"Balandya","year":"2010","journal-title":"J Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.nano.2015.03.008_bb0630","first-page":"S1","article-title":"Selective transmission of R5 HIV-1 variants: where is the gatekeeper?","volume":"9","author":"Grivel","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.nano.2015.03.008_bb0635","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-4690-11-52","article-title":"Human immature Langerhans cells restrict CXCR4-using HIV-1 transmission","volume":"11","author":"Sarrami-Forooshani","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.nano.2015.03.008_bb0640","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/QAD.0000000000000024","article-title":"HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples","volume":"28","author":"Kahle","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.nano.2015.03.008_bb0645","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2014.10.014","article-title":"Nanotech-derived topical microbicides for HIV prevention: the road to clinical development","volume":"113C","author":"Sanchez-Rodriguez","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nano.2015.03.008_bb0650","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bpobgyn.2012.01.010","article-title":"Overview of microbicides for the prevention of human immunodeficiency virus","volume":"26","author":"Abdool Karim","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.nano.2015.03.008_bb0655","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/scitranslmed.3009634","article-title":"Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides","volume":"6","author":"Zirafi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nano.2015.03.008_bb0660","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0897.2010.00932.x","article-title":"Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections","volume":"65","author":"Herold","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.nano.2015.03.008_bb0665","first-page":"135","article-title":"Humanized mouse models of HIV infection","volume":"13","author":"Denton","year":"2011","journal-title":"AIDS Rev"},{"key":"10.1016\/j.nano.2015.03.008_bb0670","doi-asserted-by":"crossref","first-page":"19159","DOI":"10.7448\/IAS.17.3.19159","article-title":"Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction","volume":"17","author":"Lanham","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.nano.2015.03.008_bb0675","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jconrel.2014.09.013","article-title":"Formulation and delivery of anti-HIV rectal microbicides: advances and challenges","volume":"194C","author":"Nunes","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.008_bb0680","first-page":"27","article-title":"Microbicide dosage forms","volume":"383","author":"Rohan","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.nano.2015.03.008_bb0685","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/jm049081q","article-title":"Validation and use of the MM-PBSA approach for drug discovery","volume":"48","author":"Kuhn","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2015.03.008_bb0690","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1073\/pnas.97.16.9026","article-title":"Energetics of the HIV gp120-CD4 binding reaction","volume":"97","author":"Myszka","year":"2000","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T13:49:20Z","timestamp":1598881760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963415000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1549963415000829"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2015.03.008","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment\/therapy","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2015.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}